PHGPx overexpression induces an increase in COX-2 activity in colon carcinoma cells.

BACKGROUND Lipid peroxidation is a constant problem that eukaryotic cells have to face. Glutathione peroxidases (GPx) are among the most effective systems that protect cells from hydroperoxide toxicity. The objective of this study was to evaluate the relationship between GPx and cyclooxygenase 2 (COX-2), implicated in cancer pathogenesis, particularly in colon cancer cells. MATERIALS AND METHODS Phospholipid hydroperoxide glutathione peroxidase (PHGPx or GPx4), which metabolizes peroxidized phospholipids, was cloned in an expression plasmid, transfected in HT29 cl.19A colon carcinoma cells and the effects of PHGPx overexpression were measured on arachidonic acid metabolism by COX-2. Metabolites were studied by HPLC and EIA; COX-2 mRNA levels were analysed rising semi-quantitative PCR. RESULTS Prostaglandins (PGE2, PGF2alpha, 6 keto-PGF1alpha) and thromboxane (TXB2) production were increased. COX-2 mRNA levels increased in PHGPx overexpressing cells. CONCLUSION Surprisingly, our data suggest that PHGPx overexpression noticeably increases COX-2 metabolism.

[1]  R. Yamazaki,et al.  Selective cyclooxygenase‐2 inhibitors show a differential ability to inhibit proliferation and induce apoptosis of colon adenocarcinoma cells , 2002, FEBS letters.

[2]  H. Suzuki,et al.  Inhibitory effect of phospholipid hydroperoxide glutathione peroxidase on the activity of lipoxygenases and cyclooxygenases. , 1999, Prostaglandins & other lipid mediators.

[3]  M. Rigaud,et al.  Cyclooxygenase-2 expression in human adenocarcinoma cell line HT29 cl.19A. , 1998, Anticancer research.

[4]  J. Morrow,et al.  Antioxidants reduce cyclooxygenase-2 expression, prostaglandin production, and proliferation in colorectal cancer cells. , 1998, Cancer research.

[5]  H. Imai,et al.  Suppression of Leukotriene Formation in RBL-2H3 Cells That Overexpressed Phospholipid Hydroperoxide Glutathione Peroxidase* , 1998, The Journal of Biological Chemistry.

[6]  J. Wal,et al.  Production of arachidonic acid metabolites by the colon adenocarcinoma cell line HT29 cl.19A and their effect on chloride secretion. , 1997, Cancer letters.

[7]  Bruno C. Hancock,et al.  Suppression of Intestinal Polyposis in Apc Δ716 Knockout Mice by Inhibition of Cyclooxygenase 2 (COX-2) , 1996, Cell.

[8]  M. Schuler.  Aspirin and the risk of colorectal cancer in women. , 1996, The New England journal of medicine.

[9]  F. Chu,et al.  Expression of selenium-dependent glutathione peroxidase in human breast tumor cell lines. , 1995, Cancer research.

[10]  J. Doroshow,et al.  Cloning and sequencing of the cDNA encoding a human testis phospholipid hydroperoxide glutathione peroxidase. , 1994, Gene.

[11]  W. Dietmaier,et al.  DISEC-TRISEC: di- and trinucleotide-sticky-end cloning of PCR-amplified DNA. , 1993, Nucleic acids research.

[12]  David A Jones,et al.  Molecular cloning of human prostaglandin endoperoxide synthase type II and demonstration of expression in response to cytokines. , 1993, The Journal of biological chemistry.

[13]  M. Thun,et al.  Aspirin use and reduced risk of fatal colon cancer. , 1991, The New England journal of medicine.

[14]  J. Doroshow,et al.  Phospholipid hydroperoxide glutathione peroxidase is the 18-kDa selenoprotein expressed in human tumor cell lines. , 1991, The Journal of biological chemistry.

[15]  A. Girotti,et al.  Protective action of phospholipid hydroperoxide glutathione peroxidase against membrane-damaging lipid peroxidation. In situ reduction of phospholipid and cholesterol hydroperoxides. , 1990, The Journal of biological chemistry.

[16]  W. Smith,et al.  The eicosanoids and their biochemical mechanisms of action. , 1989, The Biochemical journal.

[17]  B. Halliwell,et al.  Free radicals in biology and medicine , 1985 .

[18]  F. Ursini,et al.  The selenoenzyme phospholipid hydroperoxide glutathione peroxidase. , 1985, Biochimica et biophysica acta.

[19]  C. Laboisse,et al.  Emergence of permanently differentiated cell clones in a human colonic cancer cell line in culture after treatment with sodium butyrate. , 1984, Cancer research.

[20]  P. Braquet,et al.  Eosinophil-rich human polymorphonuclear leukocyte preparations characteristically release leukotriene C4 on ionophore A23187 challenge. , 1984, The Journal of allergy and clinical immunology.

[21]  F. Ursini,et al.  Purification from pig liver of a protein which protects liposomes and biomembranes from peroxidative degradation and exhibits glutathione peroxidase activity on phosphatidylcholine hydroperoxides. , 1982, Biochimica et biophysica acta.

[22]  W. Valentine,et al.  Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. , 1967, The Journal of laboratory and clinical medicine.

[23]  Oliver H. Lowry,et al.  Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.

[24]  F. Ursini,et al.  Enzymatic and immunological measurements of soluble and membrane-bound phospholipid-hydroperoxide glutathione peroxidase. , 1994, Methods in enzymology.

[25]  C. Funk,et al.  Molecular biology in the eicosanoid field. , 1993, Progress in nucleic acid research and molecular biology.